Vera Therapeutics Stock (NASDAQ:VERA), Quotes and News Summary

Q: What sector and industry does Vera Therapeutics (VERA) operate in?

Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Vera Therapeutics Stock (NASDAQ: VERA) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.406M
Day Range	- - -
52 Wk Range	6.070 - 50.780
Market Cap	$2.107B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	17.2%
Days to Cover	8.36

Recent News

Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-mediated kidney disease treatments. Analysts foresee significant revenue growth potential, with Alpine's lead molecule poised to add over $5 billion in sales.

Vandana Singh

Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.

Avi Kapoor

$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Vera Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and com...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vera Therapeutics (VERA) stock?

You can purchase shares of Vera Therapeutics (NASDAQ: VERA) through any online brokerage.

View our list of the best stock brokerages.

Who are Vera Therapeutics's (VERA) competitors?

Other companies in Vera Therapeutics’s space includes: Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), Fusion Pharmaceuticals (NASDAQ:FUSN), PTC Therapeutics (NASDAQ:PTCT) and TG Therapeutics (NASDAQ:TGTX).

What is the target price for Vera Therapeutics (VERA) stock?

The latest price target for Vera Therapeutics (NASDAQ: VERA) was reported by Guggenheim on Friday, April 5, 2024. The analyst firm set a price target for 56.00 expecting VERA to rise to within 12 months (a possible 44.74% upside). 17 analyst firms have reported ratings in the last year.

Current Stock Price for Vera Therapeutics (VERA)?

The stock price for Vera Therapeutics (NASDAQ: VERA) is $38.69 last updated April 25, 2024 at 4:20 PM EDT.

Does Vera Therapeutics (VERA) pay a dividend?

A quarterly cash dividend of $0.02 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on January 10, 1996.

When is Vera Therapeutics (NASDAQ:VERA) reporting earnings?

Vera Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Vera Therapeutics (VERA) going to split?

There is no upcoming split for Vera Therapeutics.

What sector and industry does Vera Therapeutics (VERA) operate in?

Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-